Showing results (251-260 of 315) with videos related to

Sort By:
Pageof 32
Actas Urologicas Espanolas|July 2, 2022
Surveillance and office management of low-grade Ta bladder tumorsS D Lokeshwar, S N Rahman, B H Press, et al.
The Journal of Urology|October 1, 1986
Flow cytometry versus urinary cytology in the evaluation of patients with bladder cancerW M Murphy, L D Emerson, R W Chandler, et al.
The Journal of Urology|August 1, 1995
Randomized prospective study comparing radical prostatectomy alone versus radical prostatectomy preceded by androgen blockade in clinical stage B2 (T2bNxM0) prostate cancer. The Lupron Depot Neoadjuvant Prostate Cancer Study GroupM S Soloway, R Sharifi, Z Wajsman, et al.
Cancer|September 1, 1983
A comparison of cisplatin and the combination of cisplatin and cyclophosphamide in advanced urothelial cancer. A National Bladder Cancer Collaborative Group A StudyM S Soloway, A Einstein, M P Corder, et al.
The Journal of Urology|April 1, 1981
Leiomyosarcoma of the bladder and subsequent urethral recurrenceA M Alabaster, W P Jordan, M S Soloway, et al.
Clinical Endocrinology|November 1, 1992
Prolonged treatment with finasteride (a 5 alpha-reductase inhibitor) does not affect bone density and metabolismH Matzkin, J Chen, Y Weisman, et al.
The Journal of Urology|February 1, 1983
Serial spot hydroxyproline/creatinine ratios in metastatic prostatic cancerS C Hopkins, I Nissenkorn, G M Palmieri, et al.
Seminars in Urologic Oncology|September 7, 2000
The use of video-based patient education for shared decision-making in the treatment of prostate cancerL G Gomella, P C Albertsen, M C Benson, et al.
Urology|January 1, 1996
Bicalutamide in the treatment of advanced prostatic carcinoma: a phase II multicenter trialM S Soloway, P F Schellhammer, J A Smith, et al.
The Journal of Urology|June 1, 1982
In vitro characterization of four N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide (FANFT) induced mouse bladder tumorsD D Mickey, G H Mickey, W M Murphy, et al.
Pageof 32